Evidence map›Paper›PMID 32410067›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Pretreatment with berberine protects against cisplatin-induced renal injury in male Wistar rats.

Hesameddin Allameh, Iman Fatemi, Ali Reza Malayeri, Ali Nesari, Saeed Mehrzadi, Mehdi Goudarzi

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. A Review ofMolecules (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hesameddin Allameh *Department of Persian Medicine, The School of Persian Medicine, Shahid Sadoughi University of Medical Sciences, Ardakan, Yazd, Iran.
Iman Fatemi *Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.
Ali Reza MalayeriNab'a Al-Hayat Health Research Center, Nab'a Al-Hayat Foundation for Medical Sciences and Health Care, Najaf, Iraq.
Ali NesariDepartment of Pharmacology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Saeed MehrzadiRazi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mehdi GoudarziStudent Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. gmehdi_787@yahoo.com.
Ahvaz Jundishapur University of Medical Sciences · IRIran University of Medical Sciences · IRKerman University of Medical Sciences · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

Ahvaz Jundishapur University of Medical Sciences 94S176
6 · The paper itself

Abstract

Berberine (BBR), an isoquinoline alkaloid, has been reported to be an antioxidant agent. This study was conducted to investigate the effect of BBR against nephrotoxicity induced by cisplatin (Cis) in male rats. In this experimental study, 28 Wistar male rats were randomly divided into four groups. Rats were pretreated with BBR (100 mg/kg/day, p.o.) for 7 consecutive days and Cis (7.5 mg/kg, i.p.) was administrated on the 7th day, 1 h after the last dose of BBR. Blood samples were collected to determine blood urea nitrogen (BUN) and creatinine (Cr) levels. Malondialdehyde (MDA), glutathione (GSH), protein carbonyl (PC), and nitric oxide (NO) levels and the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and myeloperoxidase (MPO) were assessed in the left renal tissue. Also, the mRNA expression of SOD2 and PGx1 was measured in the left renal tissue. The right kidney was used for histopathological evaluation. Our results revealed that the levels of Cr, BUN, MDA, NO, and PC and the MPO activity increased by Cis administration. Also, we found that Cis decreased renal GSH level and SOD, GPx, and CAT activities. Pretreatment with BBR for 7 consecutive days significantly attenuated the Cis-induced nephrotoxicity via increasing the antioxidant capacity and reducing the oxidative stress indices in the renal tissue. Moreover, the renoprotective effect of BBR was confirmed by the histopathological evaluation of the kidneys. Our results indicated that BBR has produced amelioration in biochemical indices and oxidative stress parameters against Cis-induced nephrotoxicity.

Indexed as

Acute Kidney InjuryAnimalsAntineoplastic AgentsAntioxidantsBerberineCisplatinMaleOxidative StressRatsRats, WistarAntineoplastic AgentsAntioxidantsBerberineCisplatinAntioxidantBerberineCisplatinNephrotoxicityRat

Identifiers

PMID32410067
OpenAlexW3024272042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.